Skip to main content

Find Clinical Trials

Home
Conditions
Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant

Clinical trial condition

Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant

Explore clinical trials studying Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant trial results

Active, Not Recruiting

Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer

NCT03744793

Conditions: Carcinoma, Carcinoma, Transitional Cell, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, +9 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

NCT02812420

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hydronephrosis, +30 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details